Persistence and Adherence to Cardiovascular Medicines in Australia

Persistence and Adherence to Cardiovascular Medicines in Australia

Background The burden of cardiovascular disease is increasing, with many people treated for multiple cardiovascular conditions. We examined persistence and adherence to medicines for cardiovascular disease treatment or prevention in Australia. Methods and Results Using national dispensing claims for...

Full description

Bibliographic Details
Main Authors:	Juliana de Oliveira Costa, Jialing Lin, Sallie‐Anne Pearson, Nicholas A. Buckley, Andrea L. Schaffer, Michael O. Falster
Format:	Article
Language:	English
Published:	Wiley 2023-07-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	anticoagulants antihypertensive agents cardiovascular agents cardiovascular system hypolipidemic agents
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.122.030264

Similar Items

Unlocking the Medicinal Mysteries: Preventing Lacunar Stroke with Drug Repurposing
by: Linjing Zhang, et al.
Published: (2023-12-01)

Uncontrolled and apparent treatment resistant hypertension: a cross-sectional study of Russian and Norwegian 40–69 year olds
by: Jakob Petersen, et al.
Published: (2020-03-01)

Acute poisoning by cardiovascular agents
by: Vučinić Slavica, et al.
Published: (2003-01-01)

Extreme lipoprotein(a) in clinical practice: A cross sectional study
by: Barak Zafrir, et al.
Published: (2023-03-01)

Comparative analysis of the use of lipid modifying agents in the Republic of Serbia and Nordic countries in the period 2015-2017
by: Martić Nikola B., et al.
Published: (2020-01-01)

Optimal blood pressure control with fewer antihypertensive medications: Achieved mostly in low‐risk hypertensive patients
by: Zhanyang Zhou, et al.
Published: (2024-11-01)

Efficacy and Safety of a Single-Pill Combination of Atorvastatin/Amlodipine in Patients with Arterial Hypertension and Dyslipidemia
by: Stefan Naydenov Naydenov, et al.
Published: (2018-01-01)

The association between TyG index and cardiovascular mortality is modified by antidiabetic or lipid-lowering agent: a prospective cohort study
by: Changchang Fang, et al.
Published: (2025-02-01)

Relative Contributions of Arterial Stiffness and Hypertension to Cardiovascular Disease: The Framingham Heart Study
by: Teemu J. Niiranen, et al.
Published: (2016-10-01)

Deprescribing preventive cardiovascular medication in patients with predicted low cardiovascular disease risk in general practice – the ECSTATIC study: a cluster randomised non-inferiority trial
by: Clare H. Luymes, et al.
Published: (2018-01-01)

Understanding deprescribing of preventive cardiovascular medication: a Q-methodology study in patients
by: Luymes CH, et al.
Published: (2017-05-01)

Understanding Erectile Dysfunction in Hypertensive Patients: The Need for Good Patient Management
by: Hernández-Cerda J, et al.
Published: (2020-06-01)

<i>Coriandrum sativum</i> L.: A Review on Ethnopharmacology, Phytochemistry, and Cardiovascular Benefits
by: Nisa Najibah Mahleyuddin, et al.
Published: (2021-12-01)

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study
by: Jan Basile, et al.
Published: (2018-09-01)

Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model
by: Farjana Akter, et al.
Published: (2022-03-01)

Synthesis of Dihydropyrimidines: Isosteres of Nifedipine and Evaluation of Their Calcium Channel Blocking Efficiency
by: Yasser M. Zohny, et al.
Published: (2023-01-01)

A mixed-methods approach to develop and validate the Malaysia anti-hypertensive agents non-adherence scale among hypertensive patients in Kuala Lumpur, Malaysia
by: Yew, Sheng Qian
Published: (2022)

The cardiovascular adrenergic system /
by: Lymperopoulos, Anastasios, http://id.loc.gov/authorities/names/n2015185196 editor., et al.
Published: (2015)

Novel Antithrombotic Agents in Ischemic Cardiovascular Disease: Progress in the Search for the Optimal Treatment
by: Ignacio Barriuso, et al.
Published: (2022-11-01)

Antithrombotic Therapy Recommendations in the European Society of Cardiology Guidelines: How Robust Are the Randomized Controlled Trials Underpinning Them?
by: Catarina M. dos Santos, et al.
Published: (2021-04-01)

The Cardiovascular Adrenergic System / edited by Anastasios Lymperopoulos
by: Lymperopoulos, Anastasios, editor
Published: (2015)

Effects of Lipid‐Lowering and Antihypertensive Treatments in Addition to Healthy Lifestyles in Primary Prevention: An Analysis of the HOPE‐3 Trial
by: Gilles R. Dagenais, et al.
Published: (2018-08-01)

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: review of the literature and suggestions for a friendly use
by: P. Maggi, et al.
Published: (2019-05-01)

Cardiovascular Effects of Saffron: An Evidence-Based Review
by: Maryam Kamalipour, et al.
Published: (2011-06-01)

Integrated cardiopulmonary pharmacology /
by: 329489 Colbert, Bruce J., et al.
Published: (2008)

Successful management of a pregnancy women with sudden onset of acute pancreatitis: A case report and literature review
by: Yi-Er Huang, et al.
Published: (2025-03-01)

Cardiovascular Effects of Saffron: An Evidence-Based Review
by: Shahin Akhondzadeh, et al.
Published: (2011-05-01)

The effect of Elettaria cardamomum (cardamom) on the metabolic syndrome: Narrative review
by: Roghayeh Yahyazadeh, et al.
Published: (2021-11-01)

Current antihypertensive drug therapy in 12,436 Swedish patients, 90 years and above, in relation to sex and comorbidity
by: Fredrik Wallentin, et al.
Published: (2020-05-01)

Cardiac drug therapy [electronic resource]: /
by: 249165 Khan, M. I. Gabriel, et al.
Published: (2007)

Withdrawal of antihypertensive medication in young to middle-aged adults: a prospective, single-group, intervention study
by: Hae-Young Lee, et al.
Published: (2023-01-01)

EFECTOS DE LOS MEDICAMENTOS CARDIOVASCULARES SOBRE EL GLOBO OCULAR / Effects of cardiovascular drugs on the eyeball
by: Caridad Peraza Martínez, et al.
Published: (2013-01-01)

Statins in depression: a meta-analytic, epidemiological, and experimental medicine approach
by: De Giorgi, R
Published: (2022)

DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT
by: N. В. Perepech, et al.
Published: (2018-05-01)

Hypolipidemic and antioxidative effects of Curcumin on blood parameters, humoral immunity, and jejunum histology in Hy-line hens
by: Javad Arshami, et al.
Published: (2013-04-01)

Arterial stiffness as predictive factor of cardiovascular diseases
by: Stojanov Vesna J., et al.
Published: (2019-01-01)

Drug-induced gingival enlargement: Series of cases
by: Isabella Manzur-Villalobos, et al.
Published: (2018-01-01)

Neonatal hypertension: concerns within and beyond the neonatal intensive care unit
by: Kathleen Altemose, et al.
Published: (2022-08-01)

Hypertension and Arrhythmias: A Clinical Overview of the Pathophysiology-Driven Management of Cardiac Arrhythmias in Hypertensive Patients
by: Jacopo Marazzato, et al.
Published: (2022-04-01)

Treatment patterns and use of healthcare resources of patients with atherosclerotic cardiovascular disease and hypercholesterolemia and patients with familial hypercholesterolemia in Spain: Protocol of the Reality study
by: Vivencio Barrios, et al.
Published: (2022-08-01)